BioSURE is a UK company specializing in the provision of rapid in-vitro diagnostic testing solutions.
The BioSURE COVID-19 Self-Test will be an at-home antibody test that will use technology similar to that of a pregnancy test. The lateral flow chromatography assay test will detect the presence of IgG antibodies to the COVID-19 virus, not COVID-19 itself. The BioSURE COVID-19 Self-Test will be as easy as 3 simple steps. Prick, Suck and Poke. The finger-prick blood sample will provide results in 11 minutes.
[mepr-show rules=”18700″ unauth=”message”]
The BioSURE COVID-19 Self-Test was developed in partnership with Mologic, a leading developer of lateral flow and rapid diagnostic technologies, products and services. BIoSURE has a history of innovation. It developed the first CE-marked self-test for HIV in 2015. The COVID-19 Self-Test is currently under development and price is available upon request.